Cefotetan versus conventional triple antibiotic prophylaxis in elective colorectal cancer surgery
- PMID: 20191043
- PMCID: PMC2826745
- DOI: 10.3346/jkms.2010.25.3.429
Cefotetan versus conventional triple antibiotic prophylaxis in elective colorectal cancer surgery
Abstract
This study examined infectious outcomes in elective colorectal cancer surgery between cefotetan alone or conventional triple antibiotics. From January to December 2007, 461 consecutive primary colorectal cancer patients underwent elective surgery. Group A contained 225 patients who received conventional triple antibiotics (cephalosporin, aminoglycoside and metronidazole) for prophylaxis, and group B contained 236 patients who received cefotetan alone for prophylaxis. Treatment failure was defined as the presence of postoperative infection including surgical-site infection (SSI), anastomotic leakage, and pneumonia or urinary tract infection. The two groups were similar in terms of demographics, American Society of Anesthesiologists (ASA) score, tumour location, stage, surgical approach (conventional open vs. laparoscopy-assisted), and type of operation. The treatment failure rates were 3.1% in Group A and 3.4% in Group B (absolute difference, -0.3%; 95% confidence interval [CI], 0.39 to 3.07, P=0.866), with SSI being the most common reason for failure in both groups (2.7% in Group A and 3.0% in Group B [absolute difference, -0.3%; 95% CI, 0.37 to 3.37, P=0.846]). Cefotetan alone is as effective as triple antibiotics for prophylaxis in primary colorectal cancer patients undergoing elective surgery.
Keywords: Antibiotic Prophylaxis; Cefotetan; Colorectal Neoplasms; Surgical Wound Infection.
Figures
Similar articles
-
Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.N Engl J Med. 2006 Dec 21;355(25):2640-51. doi: 10.1056/NEJMoa054408. N Engl J Med. 2006. PMID: 17182989 Clinical Trial.
-
Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery.Surg Infect (Larchmt). 2008 Apr;9(2):131-7. doi: 10.1089/sur.2007.034. Surg Infect (Larchmt). 2008. PMID: 18426345 Clinical Trial.
-
Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery.Surg Infect (Larchmt). 2008 Jun;9(3):349-56. doi: 10.1089/sur.2007.047. Surg Infect (Larchmt). 2008. PMID: 18570576 Clinical Trial.
-
Single-dose amoxycillin-clavulanic acid vs. cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized study. The PRODIGE Group.J Hosp Infect. 1992 Nov;22 Suppl A:23-32. doi: 10.1016/s0195-6701(05)80004-0. J Hosp Infect. 1992. PMID: 1362746 Clinical Trial.
-
Systemic perioperative prophylaxis in elective oncological colorectal surgery: cefotetan versus clindamicin plus aztreonam.Drugs Exp Clin Res. 1988;14(12):763-6. Drugs Exp Clin Res. 1988. PMID: 3150952 Clinical Trial.
Cited by
-
Pharmacokinetic differences between the epimers of cefotetan disodium after single intravenous injection in healthy Chinese volunteers.Eur J Drug Metab Pharmacokinet. 2011 Dec;36(4):223-8. doi: 10.1007/s13318-011-0064-7. Epub 2011 Sep 14. Eur J Drug Metab Pharmacokinet. 2011. PMID: 21915733 Clinical Trial.
-
Single-Dose Versus Multiple-Dose Prophylactic Antibiotics in Minimally Invasive Colorectal Surgery: A Propensity Score Matched Analysis.J Korean Med Sci. 2024 Dec 9;39(47):e305. doi: 10.3346/jkms.2024.39.e305. J Korean Med Sci. 2024. PMID: 39662499 Free PMC article.
-
Mechanical bowel preparation and prophylactic antibiotic administration in colorectal surgery: a survey of the current status in Korea.Ann Coloproctol. 2013 Aug;29(4):160-6. doi: 10.3393/ac.2013.29.4.160. Epub 2013 Aug 29. Ann Coloproctol. 2013. PMID: 24032117 Free PMC article.
-
Is Single-Dose Antimicrobial Prophylaxis Sufficient to Control Infections in Gastrointestinal Oncological Surgeries?Cureus. 2021 Aug 6;13(8):e16939. doi: 10.7759/cureus.16939. eCollection 2021 Aug. Cureus. 2021. PMID: 34513508 Free PMC article. Review.
-
Efforts to Prevent Surgical Site Infection After Colorectal Surgery.Ann Coloproctol. 2015 Dec;31(6):211-2. doi: 10.3393/ac.2015.31.6.211. Epub 2015 Dec 31. Ann Coloproctol. 2015. PMID: 26817015 Free PMC article. No abstract available.
References
-
- Bratzler DW, Houck PM, Richards C, Steele L, Dellinger EP, Fry DE, Wright C, Ma A, Carr K, Red L. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005;140:174–182. - PubMed
-
- Zmora O, Wexner SD, Hajjar L, Park T, Efron JE, Nogueras JJ, Weiss EG. Trends in preparation for colorectal surgery: survey of the members of the American Society of Colon and Rectal Surgeons. Am Surg. 2003;69:150–154. - PubMed
-
- Shpitz B, Reissman P, Rabau M, Ziv Y. Perioperative management of patients undergoing elective colorectal surgery in Israel: a national survey. Surg Infect (Larchmt) 2005;6:305–312. - PubMed
-
- Aoun E, El Hachem S, Abdul-Baki H, Ayyach B, Khalifeh M, Chaar H, Kanafani ZA, Kanj SS, Sharara AI. The use and abuse of antibiotics in elective colorectal surgery: the saga continues. Int J Surg. 2005;3:69–74. - PubMed
-
- Bellantone R, Pacelli F, Sofo L, Doglietto GB, Bossola M, Ratto C, Crucitti F. Systemic perioperative prophylaxis in elective oncological colorectal surgery: cefotetan versus clindamicin plus aztreonam. Drugs Exp Clin Res. 1988;14:763–766. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical